Navin Fluorine Reports Robust H1 FY27 Growth and Ongoing Strategic Expansions
Navin Fluorine International Ltd 路 Intimation 路 13 Nov 2026, 9:24 pm
Navin Fluorine Reports Robust H1 FY27 Growth and Ongoing Strategic Expansions Navin Fluorine delivered strong H1 FY27 consolidated performance, with sales increasing 51% YoY to Rs. 2,235.8 Cr and operating EBITDA growing 69% YoY to Rs. 764.5 Cr at a 34.2% margin (+367 bps YoY). Growth spanned across verticals: HPP rose 41% YoY to Rs. 1,144 Cr, Specialty Chemicals gained 53% YoY to Rs. 673 Cr, and CDMO surged 80% YoY to Rs. 419 Cr. Key capex initiatives include additional HFC capacity of up to 15,000 MTPA and the Phase II cGMP4 expansion targeted by Q4 FY27.
Original exchange filing (PDF)
More announcements from Navin Fluorine International Ltd
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 13 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of Navin Fluorine International Limited .... 路 11 Nov 2026
- Transcript of Earnings Call held for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- Newspaper Advertisement of the financial results for the quarter and half year ended September 30, 2026 路 31 Oct 2026
- Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's .... 路 31 Oct 2026
- Communication to shareholders-Intimation regarding Tax Deduction on Dividend 路 30 Oct 2026
- Investor Presentation for Q2 & H1 of Financial Year 2026-27 路 30 Oct 2026
- Intimation of Record Date for ascertaining Members eligible for the payment of interim dividend for the financial year 2026-2027 路 30 Oct 2026
